Living With Ambiguity: A Metasynthesis of Qualitative Research on Mild Cognitive Impairment

Tim Gomersall1, Arlene Astell2, Louise Nygård3

  • 1School of Health & Related Research, University of Sheffield, Sheffield, UK. nina.sperber@duke.edu.

The Gerontologist
|August 29, 2015
PubMed
Abstract

Insights

A diagnosis of Mild Cognitive Impairment (MCI) significantly impacts individuals

Area of Science:

  • Gerontology
  • Cognitive Neurology
  • Qualitative Health Research

Background:

  • Mild Cognitive Impairment (MCI) is a diagnostic category for individuals between normal aging and dementia.
  • The MCI diagnosis faces criticism regarding its conceptual clarity and societal implications for aging.
  • There is a noted tension between medical and sociological perspectives on normal aging.

Purpose of the Study:

  • To explore the lived experiences of individuals diagnosed with and living with MCI.
  • To understand the subjective impact of an MCI diagnosis on personal identity and daily life.
  • To investigate the challenges faced by individuals in comprehending and navigating their MCI diagnosis.

Main Methods:

  • A qualitative systematic review was conducted.
  • Metasynthesis was employed as the methodological framework.
  • Published qualitative literature on MCI experiences was examined.

Main Results:

  • Two key themes emerged: 'MCI and myself-in-time' and 'Living with Ambiguity'.
  • The diagnosis significantly altered individuals' self-perception and place in the world, influenced by social support and personal interpretation.
  • Participants experienced difficulties in making sense of their diagnosis due to inconsistent information and uncertainty about their condition.

Conclusions:

  • Making an MCI diagnosis involves an inherent ethical tension.
  • Early support through diagnosis may be counterbalanced by increased anxiety regarding future uncertainty.
  • Addressing the ongoing concerns and needs of individuals with MCI requires careful consideration of this ethical dilemma.

Related Concept Videos

Metacognition01:26

Metacognition

Metacognition is a conscious process where individuals are aware of their cognitive and executive processes, such as planning before solving a problem or self-monitoring during reading. For instance, a writer may need help with composing a piece. The situation involves a writer who is working on a piece of writing, but while doing so, they realize that something is missing. They notice that their characters lack depth or details. This realization occurs because the writer is reflecting on their...
1.1K
Qualitative Analysis03:46

Qualitative Analysis

For solutions containing mixtures of different cations, the identity of each cation can be determined by qualitative analysis. This technique involves a series of selective precipitations with different chemical reagents, each reaction producing a characteristic precipitate for a specific group of cations. Metal ions within a group are further separated by varying the pH, heating the mixture to redissolve a precipitate, or adding other reagents to form complex ions.
For instance, group IV...
28.7K
Qualitative Analysis01:10

Qualitative Analysis

Qualitative analysis is the process of identifying elements, ions, or compounds in an unknown sample. It is the first and most fundamental type of analysis based on the hierarchy of analytical goals. This hierarchy is significant as it provides a structured approach to scientific research, with qualitative analysis serving as the initial step, providing essential information before moving on to quantitative or other forms of analysis.
There are two main approaches to qualitative analysis:...
1.9K
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
2.0K
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
856
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
1.2K